| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Nov―15 |
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey |
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M. Bilgin, Federico Itri, Pavel Žák, Barbora Weinbergerová, Luisa Verga, Ali S. Omrani, Maria Gomes da Silva, Tomáš Szotkowski, Monia Marchetti, Caterina Buquicchio, Marcio Nucci, Martin Schönlein, Francesca Farina, Caroline Besson, Lucia Prezioso, Summiya Nizamuddin, Julio Dávila-Valls, Sonia Martín-Pérez, Valentina Bonuomo, Jaap Van Doesum, Maria Chiara Tisi, Francesco Passamonti, Gustavo-Adolfo Méndez, Stef Meers, Johan Maertens, Alberto López-García, Andreas Glenthøj, Matteo Bonnani, Ikhwan Rinaldi, Irati Ormazabal-Vélez, Jorge Labrador, Austin Kulasekararaj, Ildefonso Espigado, Fatih Demirkan, Nick De Jonge, Graham P. Collins, Maria Calbacho, Ola Blennow, Murtadha Al-Khabori, Tatjana Adžić-Vukičević, Elena Arellano, Bojana Mišković, Miloš Mladenović, Anna Nordlander, Zdeněk Ráčil, Emanuele Ammatuna, Raul Cordoba, Ditte Stampe Hersby, Stefanie Gräfe, Ziad Emarah, Michaela Hanakova, Maria Vittoria Sacchi, Marriyam Ijaz, Laman Rahimli, Raquel Nunes Rodrigues, Giovanni Paolo Maria Zambrotta, Francesco Marchesi, Oliver A. Cornely, Livio Pagano |
| 2 |
[GO] |
2023―Oct―20 |
Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes |
Emily R. Gordon, Bradley D. Kwinta, Celine M. Schreidah, Lauren M. Fahmy, Oluwaseyi Adeuyan, Dawn Queen, Megan H. Trager, Cynthia M. Magro, Larisa J. Geskin |
| 3 |
[GO] |
2023―Sep―21 |
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL |
Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun |
| 4 |
[GO] |
2023―Aug―21 |
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics |
Kathleen P. L. Cheok, Amy A. Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, Vaishali Dulobdas, David Irvine, Caroline Besley, Lorna Neil, Robert Lown, Tobias Menne, William Townsend, Andrea Kuhnl, Maeve O’Reilly, Robin Sanderson, Emilie Sanchez, Claire Roddie |
| 5 |
[GO] |
2023―Aug―14 |
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients |
Joe S. Al-Ramahi, Moazzam Shahzad, Kevin Li, Shaun DeJarnette, Sibgha Gull Chaudhary, Forat Lutfi, Nausheen Ahmed, Ramesh Balusu, Rajat Bansal, Haitham Abdelhakim, Leyla Shune, Anurag K. Singh, Sunil H. Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq |
| 6 |
[GO] |
2023―Jun―21 |
Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis |
V. G. Hall, C. Lim, N. R. Saunders, E. Klimevski, T. H. O. Nguyen, L. Kedzierski, J. F. Seymour, V. Wadhwa, K. A. Thursky, M. K. Yong, K. Kedzierska, M. A. Slavin, B. W. Teh |
| 7 |
[GO] |
2023―Mar―16 |
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data |
Christopher T. Su, Jason C. Chen, Jeremy B. Sussman |
| 8 |
[GO] |
2023―Mar―13 |
Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir |
Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach |
| 9 |
[GO] |
2023―Mar―13 |
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia |
Matteo Passerini, Tamar Ratishvili, Jonathon M. Monroe, Zelalem Temesgen, Thomas E. Witzig, Neil E. Kay, Richard B. Kennedy, Sameer A. Parikh |
| 10 |
[GO] |
2022―Nov―01 |
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era |
Alice Laurenge, Renata Ursu, Emeline Tabouret, Vincent Harlay, Guido Ahle, Sylvain Choquet, Carole Soussain, Cécile Moluçon-Chabrot, Bertrand Mathon, Karima Mokhtari, Valérie Pourcher, Lucia Nichelli, Stéphane Marot, Mehdi Touat, Khê Hoang-Xuan, Caroline Houillier |
| 11 |
[GO] |
2022―Oct―25 |
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome |
David C. Helfgott, Sabrina Racine-Brzostek, Kelsey J. Short, Zhen Zhao, Paul Christos, Itzel Nino, Tina Niu, Jorge Contreras, Ellen K. Ritchie, Pinkal Desai, Michael Samuel, Gail J. Roboz |
| 12 |
[GO] |
2022―Aug―22 |
Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathway |
Luke Carter-Brzezinski, Elizabeth Davies, Jane Norman, Lourdes Rubio, Christopher Dixon, Sarah Brett, Tony Dunne, Shahid Iqbal, Fiona L. Dignan, Shazaad Ahmad, Nicholas Machin, Henry Morriss, Anthony Wilson, Eleni Tholouli |
| 13 |
[GO] |
2022―Jun―21 |
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic |
Aditya Tedjaseputra, James A. Kuzich, Nisha Thiagarajah, Tse-Chieh Teh, Julia McClelland, Marzia Rahman, Rowena Brook, Chong Chyn Chua, Doen Ming Ong, Shuh-Ying Tan, Robin Filshie, Chun Yew Fong, Pasquale Fedele, Ashish Bajel, Jake Shortt, Andrew H. Wei |
| 14 |
[GO] |
2022―Jun―19 |
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak |
Milena Kohn, Tamim Alsuliman, Sylvain Lamure, Morgane Cheminant, Jéremy Delage, Corinne Merle De Boever, Jean Jacques Tudesq, Zora Marjanovic, Zoé Van de Wyngaert, Florent Malard, Eolia Brissot, Sophie Rigaudeau, Stéphanie Marque-Juillet, Audrey Therby, Guillaume Cartron, Philippe Rousselot, Olivier Hermine, Rémy Duléry, Caroline Besson |
| 15 |
[GO] |
2022―May―20 |
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination |
Lauren C. Shapiro, Astha Thakkar, Radhika Gali, Jesus D. Gonzalez-Lugo, Abdul-Hamid Bazarbachi, Shafia Rahman, Kith Pradhan, Karen Fehn, Michelly Abreu, Noah Kornblum, Kira Gritsman, Mendel Goldfinger, Aditi Shastri, Ioannis Mantzaris, Ira Braunschweig, Balazs Halmos, Amit Verma, Margaret McCort, Lizamarie Bachier-Rodriguez, R. Alejandro Sica |
| 16 |
[GO] |
2022―May―14 |
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination |
Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Jotham Marfil, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Ashutosh Wechalekar, Rakesh Popat, Jonathan Sive, Charalampia Kyriakou, Ke Xu, Eleni Nastouli, Kwee L. Yong, Neil Rabin |
| 17 |
[GO] |
2022―Apr―28 |
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis |
Kathleen P. L. Cheok, Amy A. Kirkwood, Tobias Menne, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, Ben Uttenthal, James Russell, David Irvine, Rod Johnson, Emma Nicholson, Jessica Bazin, William Townsend, Andrea Kuhnl, Maeve O’Reilly, Robin Sanderson, Amit Patel, Claire Roddie |
| 18 |
[GO] |
2022―Mar―27 |
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia |
Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, Luca Laurenti, Roberta Murru, Andrea Visentin, Gianluigi Reda, Francesca Romana Mauro, Giulia Quaresmini, Anna Vanazzi, Candida Vitale, Lorella Orsucci, Massimo Massaia, Alessandro Sanna, Marina Motta, Adalberto Ibatici, Isacco Ferrarini, Chiara Borella, Marzia Varettoni, Monica Tani, Sara Marinoni, Andrea Ferrario, Giulia Zamprogna, Marco Montillo, Alessandra Tedeschi |
| 19 |
[GO] |
2022―Feb―27 |
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience |
Neha Mehta-Shah, Nancy L. Bartlett, Brad Kahl, Marcus P. Watkins, Amalia Dubois, Gabby Schmelzle, Saiama Waqar, Claire Ballman, Fei Wan, Christopher W. Farnsworth |
| 20 |
[GO] |
2022―Feb―14 |
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study |
Оlga L. Kochneva, Maria Kislova, Evgenya I. Zhelnova, Andrei A. Petrenko, Elena A. Baryakh, Konstantin V. Yatskov, Elena A. Dmitrieva, Elena N. Misurina, Konstantin E. Nikitin, Elena J. Vasilieva, Inna V. Samsonova, Vadim V. Ptushkin, Ancha Baranova, Eugene A. Nikitin |
| 21 |
[GO] |
2022―Feb―02 |
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment |
Silvia Bellesi, Michela Sali, Elena Maiolo, Maria del Carmen Pereyra Boza, Eleonora Alma, Ivana Palucci, Federica Fatone, Flavio De Maio, Marcello Viscovo, Francesco D’Alò, Valerio De Stefano, Stefan Hohaus, Maurizio Sanguinetti |
| 22 |
[GO] |
2022―Jan―24 |
Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study |
Simone Claudiani, Eleanor L. Parker, Dragana Milojkovic, Carolina Rosadas, Afzal Khan, Ksenia Katsanovskaja, Federica Marchesin, Maryam Khan, Richard S. Tedder, Andrew J. Innes, Myra O. McClure, Jane F. Apperley |
| 23 |
[GO] |
2022―Jan―06 |
Telehealth access among hematology patients during the COVID-19 pandemic in Australia: a cross-sectional survey |
Nienke Zomerdijk, Michelle I Jongenelis, Jane Turner, Kathryn Huntley, Andrew Smith, Camille E. Short |
| 24 |
[GO] |
2021―Oct―28 |
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders? |
Imane Saad Albichr, Julien De Greef, Eric Van Den Neste, Xavier Poiré, Violaine Havelange, Marie-Christiane Vekemans, Sarah Bailly, Jean-Cyr Yombi, Samy Mzougui, Anaïs Scohy, Benoît Kabamba-Mukadi |
| 25 |
[GO] |
2021―Oct―21 |
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients |
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino, Rafael de la Cámara, Anna Sureda, Rebeca Rodríguez-Veiga, Ana Garrido, Jorge Sierra, José-María Ribera, Anna Torrent, María Victoria Mateos, Javier de la Rubia, Mar Tormo, María Díez-Campelo, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Juan-Manuel Sancho, Alejandro MartínGarcía-Sancho, Lucrecia Yañez, José Antonio Pérez Simón, Pere Barba, Pau Abrisqueta, Iván Álvarez-Twose, Santiago Bonanad, Ramón Lecumberri, Isabel Ruiz-Camps, David Navarro, José-Ángel Hernández-Rivas, Ángel Cedillo, Ramón García-Sanz, Francesc Bosch |
| 26 |
[GO] |
2021―Oct―20 |
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies |
Franziska Modemann, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, Susanne Ghandili |
| 27 |
[GO] |
2021―Sep―15 |
Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection |
Arthur Poncelet, Gil Verschelden, Martin Colard, Marc Hildebrand, Maya Hites, Nicolas Yin, Charlotte Michel, David Grimaldi, Virginie De Wilde |
| 28 |
[GO] |
2021―Sep―02 |
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust |
Richard Hinton, George Nesr, Catherine Garnett, David Foldes, Joel James Robert McCay, Rachael Medland, Huseini Kagdi, Vaitsa Katsomitrou, Hau Wui Sim, Sameer Gandhi, Agapi Parcharidou, Siamak Arami |
| 29 |
[GO] |
2021―Aug―26 |
Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic |
Tom Dunne, Douglas Stewart, Holly Lee, Jason Tay, Peter Duggan, Sylvia McCulloch, Paola Neri, Nizar J. Bahlis, Victor H. Jimenez-Zepeda |
| 30 |
[GO] |
2021―Aug―18 |
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome |
Ilana Levy, Avital Lavi, Eran Zimran, Sigal Grisariu, Shlomzion Aumann, Gilad Itchaki, Tamar Berger, Pia Raanani, Reut Harel, Ariel Aviv, Noa Lavi, Tsila Zuckerman, Lev Shvidel, Osnat Jarchowsky, Martin Ellis, Katrin Herzog Tzarfati, Maya Koren-Michowitz, Yehonatan Sherf, Itai Levi, Orit Sofer, Ofer Shpilberg, Nagib Dally, Celia Suriu, Andrei Braester, Sharon Ben Barouch, Merav Leiba, Daniela Goldstein, Nadav Sarid, Shay Yeganeh, Jabour Halloun, Moshe Mittelman, Tamar Tadmor |
| 31 |
[GO] |
2021―Aug―13 |
Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality |
Mirjana Mitrovic, Nikola Pantic, Nikica Sabljic, Miodrag Vucic, Zoran Bukumiric, Marijana Virijevic, Zlatko Pravdic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic |
| 32 |
[GO] |
2021―Jul―27 |
Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy |
Benjamin W. Teh, Constantine S. Tam |
| 33 |
[GO] |
2021―Jul―22 |
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group |
Tomás Palanques-Pastor, Juan Eduardo Megías-Vericat, Pilar Martínez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez Macias, Isabel Cano, Montserrat Arnan Sangerman, María Belén Vidriales Vicente, Jesús Lorenzo Algarra Algarra, María Ángeles Foncillas, Pilar Herrera, Carmen Botella Prieto, Susana Vives, Ángela Figuera Álvarez, Laida Cuevas Palomares, Marta Sobas, Alejandro Contento Gonzalo, Rebeca Cuello García, María Elena Amutio Diez, Dunia De Miguel Llorente, Begoña Navas Elorza, Juan Miguel Bergua Burgues, Teresa Bernal Del Castillo, María Carmen Mateos Rodríguez, Erik de Cabo López, Ana Carolina Franco Villegas, Raimundo García Boyero, Cristian Escolano Escobar, Cristina Seri Merino, Carlos Cervero, Alicia Roldán Pérez, Lourdes Hermosín Ramos, Marta Cervera Calvo, María Telesa Olave, Paola Villafuerte Gutiérrez, Almudena de Laiglesiai, Josefina Serrano, María Josefa Najera Irazu, José Luis Piñana, Miguel Ángel Sanz, Joaquín Martínez-López, Pau Montesinos |
| 34 |
[GO] |
2021―Jul―15 |
Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting |
Marzia Varettoni, Silvia Mangiacavalli, Sara Rattotti, Claudio Salvatore Cartia, Chiara Cavalloni, Franca Rossetti, Virginia Valeria Ferretti, Fabio Bergamini, Chiara Trotti, Nicolas Fiorelli, Giuseppina Pagani, Caterina Zerbi, Jacqueline Ferrari, Caterina Cristinelli, Alba Muzzi, Carlo Marena, Fausto Baldanti, Raffaele Bruno, Luca Arcaini |
| 35 |
[GO] |
2021―Jul―13 |
COVID-19 in chronic myeloid leukemia patients in Latin America |
Katia B. Pagnano, Evelyn Herrera Peralta, Juan Ramon Navarro, Lourdes del Rosario David Salas, Nancy Delgado, Beatriz Moiraghi, Ana Carolina M. Toreli, Leila M. Perobelli, Leonardo Fechio, Acy T. S. Quixada, Vaneuza Funke, Israel Bendit, Fernanda S. Seguro, Lilian Pilleux, Jaisson Bortolini, André L. G. Lourenço, Jaqueline Sapelli, Fabio M. Nucci, Carolina Pavlovsky, Luciene Da Cruz Oliveira, Muriel Silva Moura, Leonardo C. Palma, Natalia N. Gonçalves, Monika Conchon, Paula O.M. Hokama, Leandro Lustri Almeida, Roberto Zulli, Carmino Antonio de Souza, Carla M. Boquimpani |
| 36 |
[GO] |
2021―Jun―28 |
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality |
Maximilian Stahl, Varun Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark B. Geyer, Anthony R. Mato, Lindsey E. Roeker, Martin S. Tallman, Gunjan L. Shah, Anthony Daniyan, Aaron D. Goldberg |
| 37 |
[GO] |
2021―Jun―24 |
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients |
Marquita Camilleri, Thomas McGrath, William Wilson, Stuart J. Ings, Jacqueline Horder, Fiona Newrick, Jonathan Sive, Xenofon Papanikolaou, Rakesh Popat, Charalampia Kyriakou, Kwee Yong, Neil Rabin |
| 38 |
[GO] |
2021―Jun―21 |
COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers |
Marcus Messmer, Nina Wagner-Johnston |
| 39 |
[GO] |
2021―May―11 |
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination |
Caitlin M. Brumfiel, Meera H. Patel, David J. DiCaudo, Allison C. Rosenthal, Mark R. Pittelkow, Aaron R. Mangold |
| 40 |
[GO] |
2021―Mar―17 |
Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections |
Alain Mina, Sara Small, Leonidas C. Platanias |
| 41 |
[GO] |
2021―Feb―28 |
Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak |
A. Ramírez-López, P. Lázaro del Campo, K. Humala, B. De la Cruz Benito, I. Sánchez-Vadillo, A. López de la Guía, R. de Paz Arias, V. Jiménez-Yuste, M. Canales |
| 42 |
[GO] |
2021―Feb―23 |
Severe IgA-mediated autoimmune hemolytic anemia triggered by SARS-CoV-2 infection |
Aude Mausoleo, Soledad Henriquez, Cécile Goujard, Anne-Marie Roque-Afonso, Nicolas Noel, Olivier Lambotte |
| 43 |
[GO] |
2021―Jan―29 |
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort |
Talvinder Bhogal, Umair T. Khan, Rebecca Lee, Alexander Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, Avith Jathanna, Shaun Rahman, Ann Tivey, Rohan Shotton, Ram Sundar, Christopher Valerio, Amir Norouzi, Philip Walker, Ruth Suckling, Anne Armstrong, Gillian Brearton, Andrew Pettitt, Nagesh Kalakonda, Daniel H. Palmer, Richard Jackson, Lance Turtle, Carlo Palmieri |
| 44 |
[GO] |
2021―Jan―22 |
Anemia and red blood cell abnormalities in COVID-19 |
Philip Murphy, Siobhan Glavey, John Quinn |
| 45 |
[GO] |
2021―Jan―19 |
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies |
Silvia Ferrari, Chiara Caprioli, Alessandra Weber, Alessandro Rambaldi, Federico Lussana |
| 46 |
[GO] |
2021―Jan―10 |
Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy |
Alexis Genthon, Thibault Chiarabini, Pierre Baylac, Nadia Valin, Tomas Urbina, Jérome Pacanowski, Arsène Mekinian, Eolia Brissot, Fella M.’Hammedi-Bouzina, Simona Lapusan, Mohamad Mohty, Karine Lacombe, Patrick Ingiliz |
| 47 |
[GO] |
2020―Dec―26 |
Evolving management strategies for lymphomas during the COVID-19 pandemic |
Noemie Lang, John Kuruvilla |
| 48 |
[GO] |
2020―Dec―03 |
COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China |
Chunyan Sun, Junying Li, Hang Xiang, Chunrui Li, Anfang Shang, Wei Chang, Xiya Gui, Yadan Wang, Hongxiang Wang, Qianwen Cheng, Chun Zhang, Guolin Yuan, Chucheng Wan, Qihuan Liu, Long Wang, Zhiping Huang, Caixia Liang, Yaogong Wu, Yu Hu |
| 49 |
[GO] |
2020―Nov―10 |
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom |
Catherine Garnett, David Foldes, Chris Bailey, George Nesr, Tracy Hui, Richard Hinton, Kamala Gurung, James Phillips, Zahbia Saleem, Rincy Koshy, Elvis Aduwa, Marife Colis, Ravi Bimolah, Vaitsa Katsomitrou, Siamak Arami, Huseini Kagdi |
| 50 |
[GO] |
2020―Sep―09 |
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) |
Vincenzo Sammartano, Adele Santoni, Bruno Frediani, Anna Sicuranza, Cencini Emanuele, Federico Franchi, Enrico Capochiani, Monica Bocchia |
| 51 |
[GO] |
2020―Aug―25 |
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies |
Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, Heng Mei, Yadan Wang, Yu Hu |
| 52 |
[GO] |
2020―Jul―23 |
The management of chronic lymphoproliferative disorders at the time of SARS-Covid2 pandemic: weathering the storm |
Anna Maria Frustaci, Giulia Zamprogna, Marina Deodato, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi |
| 53 |
[GO] |
2020―Jul―09 |
Hematological manifestations of COVID-19 |
Alain Mina, Koen van Besien, Leonidas C. Platanias |
| 54 |
[GO] |
2020―Jul―02 |
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection |
Claudio Galvao de Castro Jr., Lauro Jose Gregianin, Jan A. Burger |
| 55 |
[GO] |
2020―Jun―17 |
SARS-CoV-2 in multiple myeloma: initial observation and management |
Elisabet E. Manasanch, Victor Mulanovich, Joanna-Grace Manzano, Maria Susan Gaeta, Melody Becnel, Gregory P. Kaufman, Hans C. Lee, Behrang Amini, Sheeba K. Thomas, Swaminathan P. Iyer, Donna M. Weber, Zuzana Berkova, Christopher R. Flowers, Robert Z. Orlowski, Krina K. Patel |
|
